# Hims & Hers Health, Inc.: financial statements, quarterly

HIMS · NYSE · CIK 1773751 · [Healthcare](/sectors/healthcare.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/hims.md) · [Financials](/companies/hims/financials.md) · [Filings](/companies/hims/filings.md) · [Insiders](/companies/hims/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/hims/financials.md?period=annual).

## Income statement

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [227](/filings/0001773751-24-000339.md) | [247 d](/filings/0001773751-26-000022.md) | [278](/filings/0001773751-25-000154.md) | [316](/filings/0001773751-25-000250.md) | [402](/filings/0001773751-25-000354.md) | [481 d](/filings/0001773751-26-000022.md) | [586](/filings/0001773751-26-000076.md) | [545](/filings/0001773751-26-000163.md) | [599](/filings/0001773751-25-000354.md) | [618 d](/filings/0001773751-26-000022.md) | [608](/filings/0001773751-26-000076.md) | [753](/filings/0001773751-26-000163.md) |
| Cost of revenue | $m | [39.4](/filings/0001773751-24-000339.md) | [42.6 d](/filings/0001773751-26-000022.md) | [49.1](/filings/0001773751-25-000154.md) | [59.0](/filings/0001773751-25-000250.md) | [83.7](/filings/0001773751-25-000354.md) | [112 d](/filings/0001773751-26-000022.md) | [155](/filings/0001773751-26-000076.md) | [129](/filings/0001773751-26-000163.md) | [157](/filings/0001773751-25-000354.md) | [173 d](/filings/0001773751-26-000022.md) | [211](/filings/0001773751-26-000076.md) | [272](/filings/0001773751-26-000163.md) |
| Gross profit | $m | [187](/filings/0001773751-24-000339.md) | [204 d](/filings/0001773751-26-000022.md) | [229](/filings/0001773751-25-000154.md) | [257](/filings/0001773751-25-000250.md) | [318](/filings/0001773751-25-000354.md) | [370 d](/filings/0001773751-26-000022.md) | [431](/filings/0001773751-26-000076.md) | [416](/filings/0001773751-26-000163.md) | [442](/filings/0001773751-25-000354.md) | [444 d](/filings/0001773751-26-000022.md) | [397](/filings/0001773751-26-000076.md) | [481](/filings/0001773751-26-000163.md) |
| Selling, general and administrative | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Operating income | $m | [(8.6)](/filings/0001773751-24-000339.md) | [(0.4) d](/filings/0001773751-26-000022.md) | [9.9](/filings/0001773751-25-000154.md) | [11.0](/filings/0001773751-25-000250.md) | [22.4](/filings/0001773751-25-000354.md) | [18.6 d](/filings/0001773751-26-000022.md) | [57.9](/filings/0001773751-26-000076.md) | [26.7](/filings/0001773751-26-000163.md) | [11.8](/filings/0001773751-25-000354.md) | [9.2 d](/filings/0001773751-26-000022.md) | [(78.3)](/filings/0001773751-26-000076.md) | [(97.2)](/filings/0001773751-26-000163.md) |
| Interest expense | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Income tax | $m | [0.7](/filings/0001773751-24-000339.md) | [1.0 d](/filings/0001773751-26-000022.md) | [1.3](/filings/0001773751-25-000154.md) | [0.1](/filings/0001773751-25-000250.md) | [(52.0)](/filings/0001773751-25-000354.md) | [(3.7) d](/filings/0001773751-26-000022.md) | [11.0](/filings/0001773751-26-000076.md) | [(9.7)](/filings/0001773751-26-000163.md) | [(3.6)](/filings/0001773751-25-000354.md) | [(2.2) d](/filings/0001773751-26-000022.md) | [(9.4)](/filings/0001773751-26-000076.md) | [(6.3)](/filings/0001773751-26-000163.md) |
| Net income | $m | [(7.6)](/filings/0001773751-24-000339.md) | [1.2 d](/filings/0001773751-26-000022.md) | [11.1](/filings/0001773751-25-000354.md) | [13.3](/filings/0001773751-25-000354.md) | [75.6](/filings/0001773751-25-000354.md) | [26.0 d](/filings/0001773751-26-000022.md) | [49.5](/filings/0001773751-26-000163.md) | [42.5](/filings/0001773751-26-000163.md) | [15.8](/filings/0001773751-25-000354.md) | [20.6 d](/filings/0001773751-26-000022.md) | [(92.1)](/filings/0001773751-26-000163.md) | [(86.3)](/filings/0001773751-26-000163.md) |
| Diluted EPS | $ per share | [(0.04)](/filings/0001773751-24-000339.md) | not reported | [0.05](/filings/0001773751-25-000154.md) | [0.06](/filings/0001773751-25-000250.md) | [0.32](/filings/0001773751-25-000354.md) | not reported | [0.20](/filings/0001773751-26-000076.md) | [0.17](/filings/0001773751-26-000163.md) | [0.06](/filings/0001773751-25-000354.md) | not reported | [(0.40)](/filings/0001773751-26-000076.md) | [(0.37)](/filings/0001773751-26-000163.md) |
| Basic EPS | $ per share | [(0.04)](/filings/0001773751-24-000339.md) | not reported | [0.05](/filings/0001773751-25-000154.md) | [0.06](/filings/0001773751-25-000250.md) | [0.35](/filings/0001773751-25-000354.md) | not reported | [0.22](/filings/0001773751-26-000076.md) | [0.19](/filings/0001773751-26-000163.md) | [0.07](/filings/0001773751-25-000354.md) | not reported | [(0.40)](/filings/0001773751-26-000076.md) | [(0.37)](/filings/0001773751-26-000163.md) |

- Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
- Cost of revenue: us-gaap:CostOfRevenue
- Gross profit: us-gaap:GrossProfit
- Selling, general and administrative: not reported
- Operating income: us-gaap:OperatingIncomeLoss
- Interest expense: not reported
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | Q3 FY2023 (2023-09-30) | FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | [58.0](/filings/0001773751-24-000339.md) | [96.7](/filings/0001773751-26-000022.md) | [105](/filings/0001773751-25-000154.md) | [129](/filings/0001773751-25-000250.md) | [166](/filings/0001773751-25-000354.md) | [221](/filings/0001773751-26-000022.md) | [274](/filings/0001773751-26-000076.md) | [1,125](/filings/0001773751-26-000163.md) | [346](/filings/0001773751-25-000354.md) | [229](/filings/0001773751-26-000163.md) | [222](/filings/0001773751-26-000076.md) | [610](/filings/0001773751-26-000163.md) |
| Current assets | $m | [250](/filings/0001773751-23-000278.md) | [265](/filings/0001773751-25-000062.md) | [262](/filings/0001773751-24-000132.md) | [291](/filings/0001773751-24-000248.md) | [326](/filings/0001773751-24-000339.md) | [396](/filings/0001773751-26-000022.md) | [447](/filings/0001773751-25-000154.md) | [1,356](/filings/0001773751-25-000250.md) | [845](/filings/0001773751-25-000354.md) | [768](/filings/0001773751-26-000163.md) | [1,045](/filings/0001773751-26-000076.md) | [1,385](/filings/0001773751-26-000163.md) |
| Total assets | $m | [414](/filings/0001773751-23-000278.md) | [441](/filings/0001773751-25-000062.md) | [448](/filings/0001773751-24-000132.md) | [481](/filings/0001773751-24-000248.md) | [602](/filings/0001773751-24-000339.md) | [708](/filings/0001773751-26-000022.md) | [892](/filings/0001773751-25-000154.md) | [1,878](/filings/0001773751-25-000250.md) | [2,233](/filings/0001773751-25-000354.md) | [2,155](/filings/0001773751-26-000163.md) | [2,267](/filings/0001773751-26-000076.md) | [3,629](/filings/0001773751-26-000163.md) |
| Current liabilities | $m | [82.5](/filings/0001773751-23-000278.md) | [88.5](/filings/0001773751-25-000062.md) | [93.3](/filings/0001773751-24-000132.md) | [109](/filings/0001773751-24-000248.md) | [153](/filings/0001773751-24-000339.md) | [221](/filings/0001773751-26-000022.md) | [280](/filings/0001773751-25-000154.md) | [272](/filings/0001773751-25-000250.md) | [451](/filings/0001773751-25-000354.md) | [404](/filings/0001773751-26-000163.md) | [619](/filings/0001773751-26-000076.md) | [1,483](/filings/0001773751-26-000163.md) |
| Total liabilities | $m | [85.3](/filings/0001773751-23-000278.md) | [97.2](/filings/0001773751-25-000062.md) | [104](/filings/0001773751-24-000132.md) | [119](/filings/0001773751-24-000248.md) | [162](/filings/0001773751-24-000339.md) | [231](/filings/0001773751-26-000022.md) | [342](/filings/0001773751-25-000154.md) | [1,315](/filings/0001773751-25-000250.md) | [1,652](/filings/0001773751-25-000354.md) | [1,614](/filings/0001773751-26-000163.md) | [1,821](/filings/0001773751-26-000076.md) | [3,305](/filings/0001773751-26-000163.md) |
| Shareholders' equity | $m | [329](/filings/0001773751-24-000339.md) | [344](/filings/0001773751-26-000022.md) | [344](/filings/0001773751-25-000354.md) | [362](/filings/0001773751-25-000354.md) | [440](/filings/0001773751-25-000354.md) | [477](/filings/0001773751-26-000163.md) | [549](/filings/0001773751-26-000163.md) | [563](/filings/0001773751-26-000163.md) | [581](/filings/0001773751-25-000354.md) | [541](/filings/0001773751-26-000163.md) | [446](/filings/0001773751-26-000163.md) | [324](/filings/0001773751-26-000163.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Current assets: us-gaap:AssetsCurrent
- Total assets: us-gaap:Assets
- Current liabilities: us-gaap:LiabilitiesCurrent
- Total liabilities: us-gaap:Liabilities
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [25.2 d](/filings/0001773751-24-000339.md) | [22.0 d](/filings/0001773751-26-000022.md) | [25.8](/filings/0001773751-25-000154.md) | [53.6 d](/filings/0001773751-25-000250.md) | [85.3 d](/filings/0001773751-25-000354.md) | [86.4 d](/filings/0001773751-26-000022.md) | [109](/filings/0001773751-26-000076.md) | [(19.1) d](/filings/0001773751-26-000163.md) | [149 d](/filings/0001773751-25-000354.md) | [61.3 d](/filings/0001773751-26-000022.md) | [89.4](/filings/0001773751-26-000076.md) | [(35.9) d](/filings/0001773751-26-000163.md) |
| Capital expenditure | $m | not reported | not reported | [14.0](/filings/0001773751-25-000154.md) | [6.0](/filings/0001773751-25-000250.md) | [5.9](/filings/0001773751-25-000354.md) | [26.9 d](/filings/0001773751-26-000022.md) | [59.0](/filings/0001773751-26-000076.md) | [50.4](/filings/0001773751-26-000163.md) | [69.4](/filings/0001773751-25-000354.md) | [63.9 d](/filings/0001773751-26-000022.md) | [36.3](/filings/0001773751-26-000076.md) | [32.3](/filings/0001773751-26-000163.md) |
| Share repurchases | $m | [0.0 d](/filings/0001773751-24-000339.md) | [2.0 d](/filings/0001773751-26-000022.md) | [28.1](/filings/0001773751-25-000154.md) | [19.9 d](/filings/0001773751-25-000250.md) | [30.0 d](/filings/0001773751-25-000354.md) | [5.0 d](/filings/0001773751-26-000022.md) | [0.0](/filings/0001773751-25-000154.md) | [0.0 d](/filings/0001773751-25-000250.md) | [9.5 d](/filings/0001773751-25-000354.md) | [80.5 d](/filings/0001773751-26-000022.md) | not reported | not reported |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquireProductiveAssets
- Share repurchases: us-gaap:PaymentsForRepurchaseOfCommonStock

## Shares

| Line item | Unit | Q3 FY2022 (2022-09-30) | Q1 FY2023 (2023-03-31) | Q2 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-30) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [205](/filings/0001773751-23-000278.md) | [207](/filings/0001773751-24-000132.md) | [208](/filings/0001773751-24-000248.md) | [210](/filings/0001773751-24-000339.md) | [229](/filings/0001773751-25-000154.md) | [235](/filings/0001773751-25-000250.md) | [235](/filings/0001773751-25-000354.md) | [247](/filings/0001773751-26-000076.md) | [257](/filings/0001773751-26-000163.md) | [249](/filings/0001773751-25-000354.md) | [228](/filings/0001773751-26-000076.md) | [232](/filings/0001773751-26-000163.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:47 ET. No prices; not investment advice.